Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area, By Type of software solution, By Mode of Deployment, By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization) , By Region, And By Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Cell and Gene Therapy Supply Chain/Logistics Market Snapshot Chapter 4. Global Cell and Gene Therapy Supply Chain/Logistics Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Application Area Estimates & Trend Analysis 5.1. By Applications & Market Share, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Application Area: 5.2.1. Donor eligibility assessment 5.2.2. Sample collection 5.2.3. Manufacturing 5.2.4. Logistics 5.2.5. Patient verification and treatment follow-up Chapter 6. Market Segmentation 1: By Type of Software Solution Estimates & Trend Analysis 6.1. By Applications & Market Share, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Type of Software Solution: 6.2.1. Cell orchestration platform 6.2.2. Enterprise manufacturing system 6.2.3. Inventory management system 6.2.4. Laboratory information management system 6.2.5. Logistics management system 6.2.6. Patient management system 6.2.7. Quality management system 6.2.8. Tracking and tracing system Chapter 7. Market Segmentation 1: By End-User Estimates & Trend Analysis 7.1. By Applications & Market Share, 2024 & 2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By End-User: 7.2.1. Biobank 7.2.2. Cell Therapy Lab 7.2.3. Hospital 7.2.4. Research Institute 7.2.5. Commercial Organization Chapter 8. Market Segmentation 2: By Mode of Deployment Estimates & Trend Analysis 8.1. By Types & Market Share, 2024 & 2034 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Mode of Deployment: 8.2.1. Cloud 8.2.2. On-premises Chapter 9. Cell and Gene Therapy Supply Chain/Logistics Market Segmentation 3: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034 9.1.2. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034 9.1.3. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034 9.1.4. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034 9.1.5. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 9.2. Europe 9.2.1. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034 9.2.2. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034 9.2.3. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2021-2034 9.2.4. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034 9.2.5. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034 9.3. Asia Pacific 9.3.1. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034 9.3.2. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034 9.3.3. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2021-2034 9.3.4. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034 9.3.5. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034 9.4. Latin America 9.4.1. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034 9.4.2. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034 9.4.3. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million) 9.4.4. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034 9.4.5. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034 9.5. Middle East & Africa 9.5.1. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034 9.5.2. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034 9.5.3. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million) 9.5.4. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034 9.5.5. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034 Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. Be The Match BioTherapies 10.2.2. MAK-SYSTEM 10.2.3. Cryoport 10.2.4. Brooks Life Sciences 10.2.5. Lykan Bioscience 10.2.6. Clarkston Consulting 10.2.7. SAP 10.2.8. Hypertrust Patient Data Care 10.2.9. Haemonetics 10.2.10. MasterControl 10.2.11. TraceLink 10.2.12. SAVSU Technologies 10.2.13. TrakCel 10.2.14. Title21 Health Solutions 10.2.15. sedApta Group 10.2.16. Vineti 10.2.17. Stafa Cellular Therapy 10.2.18. Thermo Fisher Scientific(Patheon) 10.2.19. McKesson 10.2.20. Biocair 10.2.21. Marken(UPS Company) 10.2.22. Modality Solutions 10.2.23. Almac 10.2.24. Arvato Supply Chain Solutions SE 10.2.25. Catalent, Inc 10.2.26. BioLife Solutions, Inc 10.2.27. Biostor Ltd 10.2.28. Yourway Biopharma Services Company 10.2.29. Atelerix Ltd 10.2.30. Other Prominent Players